Altered claudin expression is a feature of chronic plaque psoriasis

Journal of Pathology

Volumn 212, Issue 4, 2007, Pages 450-458

  Watson, Rachel E B ^a   Poddar, R ^a   Walker, J M ^a   McGuill, I ^a   Hoare, L M ^a   Griffiths, C E M ^a   O'Neill, C A ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Claudin; Cytokine; Interleukin; Psoriasis; Tight junction; Tumour necrosis factor

Indexed keywords

CLAUDIN; CLAUDIN 1; CLAUDIN 11; CLAUDIN 12; CLAUDIN 14; CLAUDIN 15; CLAUDIN 16; CLAUDIN 17; CLAUDIN 18; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; CLAUDIN 5; CLAUDIN 7; CLAUDIN 8; CLAUDIN 9; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL ADHESION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; EPIDERMIS; EPITHELIUM CELL; FEMALE; GRANULAR CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSORIASIS; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY; TIGHT JUNCTION;

ADULT; AGED; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; KERATINOCYTES; MALE; MEMBRANE PROTEINS; MICROSCOPY, CONFOCAL; MIDDLE AGED; POLYMERASE CHAIN REACTION; PSORIASIS; SKIN; TIGHT JUNCTIONS;

EID: 34547119065     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2200     Document Type: Article

References (35)

1. Farquhar MG, Palade GE Junctional complexes in various epithelia. J Cell Biol 1963;17:375-412.
2. Cereijido M, Valdes J, Shoshani L, Contreras RG Role of tight junctions in establishing and maintaining cell polarity. Annu Rev Physiol 1998;60:161-177.
3. Staehelin LA Structure and function of intercellular junctions. Int Rev Cytol 1974;39:191-283.
4. Staehelin LA Further observations on the fine structure of freeze-cleaved tight junctions. J Cell Sci 1973;13:763-786.
5. Furuse M, Sasaki H, Fujimoto K, Tsukita S A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol 1998;143:391-401.
6. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002;156:1099-1111.
7. Wan H, Winton HL, Soeller C, Tovey ER, Gruenert DC, Thompson PJ et al. Der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999; 104:123-133.
8. Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, Bentzel CJ et al. Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 1999;116:301-309.
9. Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol 2001;159:2001-2009.
10. Griffiths CEM, Voorhees JJ Psoriasis, T cells and autoimmunity. J R Soc Med 1996;89:315-319.
11. Travassos WJ, Cheifetz AS Infliximab: use in inflammatory bowel disease. Curr Treat Options Gastroenterol 2005;8:187-196.
12. Griffiths CEM T cell-targeted biologicals for psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:157-161.
13. Kirby B, Griffiths CEM Novel immune-based therapies for psoriasis. Br J Dermatol 2002;146:546-551.
14. Lowes MA, Bowcock AM, Krueger JG Nature 2007;445:866-873.
15. Stefanini M, De Martino C, Zamboni L Fixation of ejaculated spermatozoa for electron microscopy. Nature 1967;216:173-174.
16. Watson REB, Griffiths CEM, Craven NM, Shuttleworth CA, Kielty CM Fibrillin-rich microfibrils are reduced in photoaged skin: distribution at the dermal -epidermal junction. J Invest Dermatol 1999; 112:782-787.
17. McLaughlin J, Padfield PJ, Burt JP, O'Neill CA Ochratoxin A increases permeability through tight junctions by removal of specific claudin isoforms. Am J Physiol Cell Physiol 2004;287:1412-1417.
18. Ivanov AI, Nusrat A, Parkos CA The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption. Novartis Found Symp 2004;263:124-132.
19. Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE Claudin-1 is a strong prognostic indicator in stage II colonic cancer. Mod Pathol 2005;18:511-518.
20. Brandner JM, Kief S, Grund C, Rendl M, Houdek P, Kuhn C et al. Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur J Cell Biol 2002; 81:253-263.
21. Tebbe B, Mankertz J, Schwarz C, Amasheh S, Fromm M, Assaf C et al. Tight junction proteins: a novel class of integral membrane proteins. Expression in human epidermis and in HaCaT keratinocytes. Arch Dermatol Res 2002;294:14-18.
22. Capon F, Trembath RC, Barker JN An update on the genetics of psoriasis. Dermatol Clin 2004;22:339-347.
23. Bowcock AM Psoriasis genetics: the way forward. J Invest Dermatol 2004;122(6):xv-xvii.
24. Lee FI, Bellary SV, Francis C Increased occurrence of psoriasis in patients with Crohn's disease and their relatives. Am J Gastroenterol 1990;85:962-963.
25. Tavarela Veloso F Skin complications associated with inflammatory bowel disease. Aliment Pharmacol Ther 2004;20(S4):50-53.
26. Bowcock AM, Shannon W, Du F, Duncan J, Cao K, Aftergut K et al. Insights into psoriasis and other inflammatory diseases from large-scale gene expression studies. Hum Mol Genet 2001;10:1793-1805.
27. Yoshida Y, Morita K, Mizoguchi A, Ide C, Miyachi Y Altered expression of occluding and tight junction formation in psoriasis. Arch Dermatol Res 2001;293:239-244.
28. Pummi K, Malminen M, Aho H, Karvonen SL, Peltonen J, Peltonen S Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing and affected skin and in vitro differentiating keratinocytes. J Invest Dermatol 2001;117:1050-1058.
29. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, et al. TNFα-induced increase in intestinal epithelial tight junction permeability requires NF-κB activation. Am J Physiol Gastrointest Liver Physiol 2004;286:G367-376.
30. Cumberbatch M, Dearman RJ, Kimber I Langerhans cells require signals from both tumour necrosis factor-α and interleukin-1β for migration. Adv Exp Med Biol 1997;417:125-128.
31. Mielke V, Bauman JG, Sticherling M, Ibs T, Zomershoe AG, Seligmann K et al. Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1α and human recombinant tumor necrosis factor-α-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization study. J Immunol 1990;144:153-161.
32. Lawley TJ, Kubota Y Cell adhesion molecules and cutaneous inflammation. Semin Dermatol 1991;10:256-259.
33. Hammerberg C, Bata-Csorgo Z, Voorhees JJ, Cooper KD IL-1 and IL-1 receptor antagonist regulation during keratinocyte cell cycle and differentiation in normal and psoriatic epidermis. Arch Dermatol Res 1998;290:367-374.
34. Gruaz DC, Didierjean L, Gumowski-Sunek D, Saurat JH Effect of topical retinoic acid on the interleukin-1α and -β immunoreactive pool in normal human epidermis. Br J Dermatol 1990; 123:283-289.
35. Yoshinaga Y, Higaki M, Terajima S, Ohkubo E, Nogita T, Miyasaka N, et al. Detection of inflammatory cytokines in psoriatic skin. Arch Dermatol Res 1995;287:158-164.